These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39186107)

  • 1. [The challenges for psychiatric care posed by synthetic drugs].
    Scherbaum N; Bonnet U
    Nervenarzt; 2024 Sep; 95(9):818-823. PubMed ID: 39186107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
    Strube J; Schaper A
    Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health.
    Lovrecic B; Lovrecic M; Gabrovec B; Carli M; Pacini M; Maremmani AGI; Maremmani I
    Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30634521
    [No Abstract]   [Full Text] [Related]  

  • 7. The Growing Problem of New Psychoactive Substances (NPS).
    Madras BK
    Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cathinones: a new public health problem.
    Karila L; Megarbane B; Cottencin O; Lejoyeux M
    Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scheduling of new psychoactive substance the Swiss way: A review and critical analysis.
    Grafinger KE; Bernhard W; Weinmann W
    Sci Justice; 2019 Jul; 59(4):459-466. PubMed ID: 31256819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
    Rousis N; Bade R; Romero-Sánchez I; Mueller JF; Thomaidis NS; Thomas KV; Gracia-Lor E
    Environ Int; 2023 Aug; 178():108075. PubMed ID: 37399770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of synthetic substances in France and in Europe].
    Debruyne D; Monzon E; Perino J; Haramburu F; Daveluy A; Lazès-Charmetant A; Giraudon I
    Therapie; 2021; 76(3):221-228. PubMed ID: 32859404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cathinones - From natural plant stimulant to new drug of abuse.
    Pieprzyca E; Skowronek R; Nižnanský Ľ; Czekaj P
    Eur J Pharmacol; 2020 May; 875():173012. PubMed ID: 32087255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives.
    Radaelli D; Manfredi A; Zanon M; Fattorini P; Scopetti M; Neri M; Frisoni P; D'Errico S
    Curr Neuropharmacol; 2021; 19(11):2038-2048. PubMed ID: 33845747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects.
    Taflaj B; La Maida N; Tittarelli R; Di Trana A; D'Acquarica I
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
    Scherbaum N; Schifano F; Bonnet U
    Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
    Niebel A; Pragst F; Krumbiegel F; Hartwig S
    Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.
    Varì MR; Mannocchi G; Tittarelli R; Campanozzi LL; Nittari G; Feola A; Umani Ronchi F; Ricci G
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33238595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
    Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.